Richard Charles Coulon

Accuitis, Inc. operates as a pre-clinical-stage biopharmaceutical company. It develops first-in-class drug therapies to treat chronic diseases of the skin and eye. The firm engages in the acquisition and development of pharmaceuticals targeting niche, orphan, and underserved disease states. The company was founded on December 13, 2011 and is headquartered in Alpharetta, GA.

Auriga Laboratories, Inc. is a specialty pharmaceutical company, which is engaged in the commercialization, licensing and development of prescription pharmaceutical products. Its products are focused in the respiratory, dermatology CNS and anti-infective therapeutic categories and are marketed to primary care physicians, pediatricians, dermatologists, urologists, psychiatrists and rheumatologists. The company was founded on April 12, 2005 and is headquartered in Camarillo, CA.